Hypereosinophilic Syndrome Following the BNT162b2 (BioNTech Pfizer) Vaccine Successfully Treated with Mepolizumab, A Case Report and Review of the Literature
Severe refractory warm autoimmune haemolytic anaemia after the SARS-CoV-2 Pfizer-BioNTech vaccine (BNT162b2 mRNA) managed with emergency splenectomy and complement inhibition with eculizumab
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT), a case report of the first reported case in Thailand